RPID earnings call for the period ending June 30, 2022.
LOWELL, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology...
Shareholders Do Not Need to Take Action at This Time...
RPID earnings call for the period ending March 31, 2022.
Reports first quarter 2022 commercial revenue of $4.2 million Reaffirms full year 2022 commercial revenue outlook range of $27 million to $32 million,...
LOWELL, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology...
RPID earnings call for the period ending December 31, 2021.
Reports fourth quarter 2021 total revenue of $5.2 million and commercial revenue of $4.9 million Reports full year 2021 total revenue of $23.2 million and...
LOWELL, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology...
LOWELL, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life...